Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regression
Adam Nelson, Simon Gebremeskel, Brian D. Lichty, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 3, pp. e003923-e003923
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy
Shashi Gujar, Jonathan Pol, K. Vishnupriyan, et al.
Nature Protocols (2024) Vol. 19, Iss. 9, pp. 2540-2570
Closed Access | Times Cited: 15
Opportunities and challenges of combining adoptive cellular therapy with oncolytic virotherapy
Joseph Mamola, Chun‐Yu Chen, Mark A. Currier, et al.
Molecular Therapy — Oncolytics (2023) Vol. 29, pp. 118-124
Open Access | Times Cited: 12
Immune Checkpoint Inhibitor-Based Combination Therapy for Colorectal Cancer: An Overview
Jingjing Li, Xuan-Fu Xu
International Journal of General Medicine (2023) Vol. Volume 16, pp. 1527-1540
Open Access | Times Cited: 11
PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity
Emmanuelle Moraes Ribeiro, Kathy-Ann Secker, Ana-Maria Nitulescu, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 1, pp. e007829-e007829
Open Access | Times Cited: 4
Fusogenic vesicular stomatitis virus combined with natural killer T cell immunotherapy controls metastatic breast cancer
Adam Nelson, Nichole McMullen, Simon Gebremeskel, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 4
The key role of immunomodulatory cytokines for the development of novel NK cell-based cancer therapies
A.A. Câmara, Diego Barriales, Ainara Azueta Etxebarría, et al.
International review of cell and molecular biology (2025)
Closed Access
Based on the immune system: the role of the IL-2 family in pancreatic disease
Yuqing Zhu, Zheng Lu, Zhuo Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Tumor microbiome: roles in tumor initiation, progression, and therapy
Shengxin Zhang, Jing Huang, Z. X. Jiang, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
Recent advances in oncolytic virus combined immunotherapy in tumor treatment
Xiaoli Zhou, Shunfeng Hu, Xin Wang
Genes & Diseases (2025), pp. 101599-101599
Open Access
NKT Cells in Tumor Immunity In: Encyclopedia of Immunobiology
Masaki Terabe, Jay A. Berzofsky
Elsevier eBooks (2025)
Closed Access
Exploring in vivo combinatorial chemo-immunotherapy: Addressing p97 suppression and immune reinvigoration in pancreatic cancer with tumor microenvironment-responsive nanoformulation
Yu‐Li Lo, Ching-Yao Li, Tsui‐Fen Chou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116660-116660
Open Access | Times Cited: 3
Intratumoral NKT cell accumulation promotes antitumor immunity in pancreatic cancer
Jiayun Li, Philip Moresco, Douglas T. Fearon
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 29
Open Access | Times Cited: 3
Oncolytic Viruses as Reliable Adjuvants in CAR-T Cell Therapy for Solid Tumors
Ruxandra Ilinca Stilpeanu, Bianca Stefania Secara, Mircea Cretu-Stancu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11127-11127
Open Access | Times Cited: 3
Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical
Chao Tang, Lan Li, Tong Mo, et al.
Clinical & Translational Oncology (2022) Vol. 24, Iss. 9, pp. 1682-1701
Open Access | Times Cited: 16
Mitochondrial damage-associated molecular patterns trigger arginase-dependent lymphocyte immunoregulation
Lauren P. Westhaver, Sarah Nersesian, Adam Nelson, et al.
Cell Reports (2022) Vol. 39, Iss. 8, pp. 110847-110847
Open Access | Times Cited: 14
Intratumoral IL15 Improves Efficacy of Near-Infrared Photoimmunotherapy
Hiroshi Fukushima, Aki Furusawa, Takuya Kato, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 10, pp. 1215-1227
Closed Access | Times Cited: 8
Novel mesothelin-targeted chimeric antigen receptor-modified UNKT cells are highly effective in inhibiting tumor progression
Wei Jiang, Guosheng Gu, Yumin Zhang, et al.
Pharmacological Research (2023) Vol. 197, pp. 106942-106942
Open Access | Times Cited: 8
An innovative nanoformulation utilizing tumor microenvironment-responsive PEG-polyglutamic coating and dynamic charge adjustment for specific targeting of ER stress inducer, microRNA, and immunoadjuvant in pancreatic cancer: In vitro investigations
Ching-Yao Li, Tsui‐Fen Chou, Yu‐Li Lo
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127905-127905
Closed Access | Times Cited: 7
Recombinant Viral Vectors for Therapeutic Programming of Tumour Microenvironment: Advantages and Limitations
Karīna Spunde, Ksenija Korotkaja, Anna Zajakina
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2142-2142
Open Access | Times Cited: 12
New avenues for the treatment of immunotherapy-resistant pancreatic cancer
Luis Guilherme de Oliveira Silva, Fabian Fellipe Bueno Lemos, Marcel Silva Luz, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 4, pp. 1134-1153
Open Access | Times Cited: 2
Optimizing Pancreatic Cancer Therapy: The Promise of Immune Stimulatory Oncolytic Viruses
Shivani Thoidingjam, Aseem Rai Bhatnagar, Sushmitha Sriramulu, et al.
(2024)
Open Access | Times Cited: 2
Optimizing Pancreatic Cancer Therapy: The Promise of Immune Stimulatory Oncolytic Viruses
Shivani Thoidingjam, Aseem Rai Bhatnagar, Sushmitha Sriramulu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9912-9912
Open Access | Times Cited: 2
Oncolytic adenovirus-mediated dual knockdown of survivin and OCT4 improves therapeutic efficacy in esophageal cancer
Chun Guang Li, Maoling Zhu, Qijue Lu, et al.
Annals of Translational Medicine (2023) Vol. 11, Iss. 5, pp. 193-193
Open Access | Times Cited: 5
Synergistic effects of Smac mimetic APG-1387 with anti-PD-1 antibody are attributed to increased CD3 + NK1.1 + cell recruitment secondary to induction of cytokines from tumor cells
Wentao Pan, Qiuyun Luo, Eric Liang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top